Rate of Isolation and Trends of Antimicrobial Resistance of Multidrug Resistant Pseudomonas Aeruginosa from Otorrhea in Chronic Suppurative Otitis Media
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives. To assess the rate of isolation of Pseudomonas aeruginosa (PA) and multidrug-resistant PA (MDR-PA) from patients with chronic suppurative otitis media (CSOM) otorrhea and the annual trend of antibiotic-resistance. Methods. Otorrhea samples were collected aseptically from 1,598 CSOM patients. The rate of bacterial isolation and the results of antibiotic susceptibility testing were evaluated retrospectively. Results. The PA isolation rate from CSOM otorrhea was 24.4%. Of the 398 isolated strains tested for their susceptibilities to 10 antibiotics, 395 strains showed definitive results. Of these, 183 (46.3%) were susceptible to whole antibiotics and 212 (53.7%) was resistant to more than 1 antibiotics, with the frequency of antibiotics-resistance increasing significantly over time. Although strains susceptible to all antibiotics decreased over time, the rate of isolation of MDRPA did not change significantly. Resistance to aminoglycosides and quinolones was higher than to other antibiotics and significantly increased over time, whereas resistance to other antibiotics showed no trend. Conclusion. MDR-PA, assessed using five individual antibiotics and six antibiotic-classes, showed no tendency to increase or decrease over time. This may have been due to increased concern about antibiotic-resistant bacterial strains, leading to improved infection control within hospitals and healthcare centers.
Abstract
Objectives. To assess the rate of isolation of Pseudomonas aeruginosa (PA) and multidrug-resistant PA (MDR-PA) from patients with chronic suppurative otitis media (CSOM) otorrhea and the annual trend of antibiotic-resistance. Methods. Otorrhea samples were collected aseptically from 1,598 CSOM patients. The rate of bacterial isolation and the results of antibiotic susceptibility testing were evaluated retrospectively. Results. The PA isolation rate from CSOM otorrhea was 24.4%. Of the 398 isolated strains tested for their susceptibilities to 10 antibiotics, 395 strains showed definitive results. Of these, 183 (46.3%) were susceptible to whole antibiotics and 212 (53.7%) was resistant to more than 1 antibiotics, with the frequency of antibiotics-resistance increasing significantly over time. Although strains susceptible to all antibiotics decreased over time, the rate of isolation of MDRPA did not change significantly. Resistance to aminoglycosides and quinolones was higher than to other antibiotics and significantly increased over time, whereas resistance to other antibiotics showed no trend. Conclusion. MDR-PA, assessed using five individual antibiotics and six antibiotic-classes, showed no tendency to increase or decrease over time. This may have been due to increased concern about antibiotic-resistant bacterial strains, leading to improved infection control within hospitals and healthcare centers.
참고문헌 (22)
- Bergogne-Berezin E, "Pseudomonas and miscellaneous gram-negative bacilli, In Infectious diseases. 2nd", pp.2203~2226 (2004), Mosby
- Song W, "In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa", Int J Antimicrob Agents, 21(1), pp.8~12 (2003)
- 이혜련, "Antimicrobial resistance of Staphylococcus from otorrhea in chronic suppurative otitis media and comparison with results of all isolated Staphylococci", EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 27(7), pp.571~577, SPRINGER
- Wikler MA, "Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement" (2006), Clinical and Laboratory Standards Institute
- Livermore DM, "Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?", Clin Infect Dis, 34(5), pp.634~640 (2002)
- Pollack M, "Pseudomonas aeruginosa, In Mandell, Douglas and Bennett’s principles and practice of infectious diseases. 5th ed", pp.2310~2327 (2000), Churchill Livingstone
- Jones RN, "Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000)", Diagn Microbiol Infect Dis, 43(3), pp.239~243 (2002)
- Walsh TR, "Evolution of an integron carrying blaVIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program", J Antimicrob Chemother, 52(1), pp.116~119 (2003)
- Carmeli Y, "Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents", Antimicrob Agents Chemother, 43(6), pp.1379~1382 (1999)
- Llano-Sotelo B, "Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site", Chem Biol, 9(4), pp.455~463 (2002)
- MacLeod DL, "Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment", J Infect Dis, 181(3), pp.1180~1184 (2000)
- Jo JT, "Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteins", Antimicrob Agents Chemother, 47(3), pp.1101~1111 (2003)
- Doi Y, "16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides", Clin Infect Dis, 45(1), pp.88~94 (2007)
- Hooper DC, "Emerging mechanisms of fluoroquinolone resistance", Emerg Infect Dis, 7(2), pp.337~341 (2001)
- Masuda N, "Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa", Antimicrob Agents Chemother, 44(12), pp.3322~3327 (2000)
- Vahaboglu H, "Resistance to extended-spectrum cephalosporins, caused by PER-1 beta-lactamase", J Med Microbiol, 43(4), pp.294~299 (1995)
- Mugnier P, "A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa", Antimicrob Agents Chemother, 40(11), pp.2488~2493 (1996)
- Watanabe M, "Transferable imipenem resistance in Pseudomonas aeruginosa", Antimicrob Agents Chemother, 35(1), pp.147~151 (1991)
- 이경원, "Increasing Prevalence of Vancomycin-Resistant Enterococci, and Cefoxitin-, Imipenem- and Fluoroquinolone-Resistant Gram-Negative Bacilli: a KONSAR Study in 2002", Yonsei Medical Journal, 45(4), pp.598~608 (2004), 연세대학교의과대학
- 이혁민, "2004년도 국내 12개 병원에서 분리된 주요 세균의 항균제 내성율", Annals of Clinical Microbiology, 8(1), pp.66~73 (2005), 대한임상미생물학회
- Falagas ME, "Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections", Clin Infect Dis, 40(9), pp.1333~1341 (2005)
- Falagas ME, "Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria", BMC Infect Dis, 8(5), pp.24~ (2005)